CHKM, ALXN, RDDY, HOLI, FSIN, EXAR are Stocks to Watch on Jan-9 AfternoonBeacon Equity ResearchTheir market cap is 13.82B . Alexion Pharmaceuticals, Inc is engaged in the discovery, development and delivery of biologic therapeutic products and life-thr…
Investigational RCC agent improves progression-free survival – ModernMedicine
Investigational RCC agent improves progression-free survivalModernMedicineAll 517 patients in the study had clear cell RCC, had undergone a prior nephrectomy, and had not previously been treated with either a vascular endothelial growth factor or mamma…
Patients suffer for govt's slow response – Daily Star Online
Patients suffer for govt's slow responseDaily Star OnlineCurrently the country hosts only kidney transplantation with 120 transplants being carried out yearly against a demand for 20000, they said. The discussion, “Organ Transplantation in Bangla…
52 Week Highs: AAPL, ACHN, ALOG, ALXN, AMSWA, ANLY – TomRollins.com
52 Week Highs: AAPL, ACHN, ALOG, ALXN, AMSWA, ANLYTomRollins.com… development and commercialization of therapeutic products aimed at treating patients with severe and life-threatening disease states, including those in the therapeutic areas of hemato…
Scottish News: Hospital celebrates 1000th liver and kidney transplants as … – Scottish Daily Record
Scottish News: Hospital celebrates 1000th liver and kidney transplants as …Scottish Daily RecordShe said: "Liver transplantation in particular is seeing increasing pressures, with more and more people needing transplant ops and I hope that this …
Black Sabbath Guitarist Tony Iommi Diagnosed With Lymphoma – Rock Sins
Rock SinsBlack Sabbath Guitarist Tony Iommi Diagnosed With LymphomaRock SinsTreatment might involve chemotherapy and in some cases radiotherapy and/or bone marrow transplantation, and can be curable depending on the histology, type, and stage of the di…
MS, virus link shown in new findings – eMaxHealth
MS, virus link shown in new findingseMaxHealthThe research means there may be ways to halt the progression of multiple sclerosis with anti-viral drugs or Rituximab, a drug that kills immune cells that harbor the virus. The study also found a possible l…
Biogen Idec présente ses priorités stratégiques pour 2012 lors de la 30ème … – TF1
Biogen Idec présente ses priorités stratégiques pour 2012 lors de la 30ème …TF1… qui auront tous deux des données publiées cette année. poursuivant le développement du programme de phase 3 du daclizumab pour la SP. renforçant les collabora…
Omni Bio Pharmaceutical to Present at Noble Financial Capital Markets' Eighth … – MarketWatch (press release)
Omni Bio Pharmaceutical to Present at Noble Financial Capital Markets' Eighth …MarketWatch (press release)Novel discoveries made at UCD indicate that AAT has the potential to address a variety of indications in the areas of diabetes, transplant r…
Biogen Idec presenta le priorità strategiche per il 2012 in occasione della … – ANSA.it
Biogen Idec presenta le priorità strategiche per il 2012 in occasione della …ANSA.it… lancio ea richieste normative successivi. realizzazione del programma di fase 3 per il daclizumab nella SM. approfondimento delle collaborazioni strategiche esis…